Manipulating the immune system with DNA vaccines shows promise for protecting against pathogens and suppressing autoimmune disease (pages 888–905).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Huygen, K. et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med. 2, 893–898 (1996).
Tascon, R.E. et al. Vaccination against tuberculosis by DNA injection. Nature Med. 2, 888–892 (1996).
Waisman, A. et al. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nature Med. 2, 899–905 (1996).
Pardoll, D.M. & Beckerleg, A.M. Exposing the immunology of naked DNA vaccines. Immunity 3, 165–169 (1995).
Hohlfeld, R. & Engel, A.G. The immunobiology of muscle. Immunol. Today 15, 269–274 (1994).
Bird, A. The essentials of DNA methylation. Cell 70, 5–8 (1992).
Pisetsky, D.S. The immunologic properties of DNA. J. Immunol. 156, 421–423 (1996).
Vandenbark, A.A. et al. Immunization with a synthetic T cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341, 541–544 (1989).
Howell, M.D. et al. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246, 668–670 (1989).
Kumar, V. & Sercarz, E. The involvement of TcR-peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178, 909–916 (1993).
Kumar, V. & Sercarz, E. Dysregulation of potentially pathogenic self reactivity is crucial for the manifestation of clinical autoimmunity. J. Neurosci. Res. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kumar, V., Sercarz, E. Genetic vaccination: The advantages of going naked. Nat Med 2, 857–859 (1996). https://doi.org/10.1038/nm0896-857
Issue Date:
DOI: https://doi.org/10.1038/nm0896-857
This article is cited by
-
Systemic administration of naked DNA with targeting specificity to mammalian kidneys
Gene Therapy (2005)
-
Insertion of the DNA for the 163–171 peptide of IL1β enables a DNA vaccine encoding p185neu to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice
Gene Therapy (2001)
-
Transfected human dendritic cells to induce antitumor immunity
Gene Therapy (2000)
-
Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen β-galactosidase and the BALB/c Meth A p53 tumor-specific antigen
Gene Therapy (1999)
-
New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet
Nature Medicine (1999)